Gelesis Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Gelesis Holdings Inc inventory turnover ratio, the Gelesis Holdings Inc 's ability to sell and replace its inventory in the second quarter 2023, sequentially increased to 2.12 in the second quarter 2023, a new company high. Average inventory processing period, for the Gelesis Holdings Inc in Jun 30 2023 quarter, has decreased to 172 days, compare to 191 days, in the Mar 31 2023 quarter.

Within Healthcare sector 214 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2023, to 1239, from total ranking in the first quarter 2023 at 1383.

GLS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Gelesis Holdings Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GLS Inventory Turnover Ratio	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Inventory Growth	-69.78 %	-63.5 %	-	-	-
Y / Y Cost of Sales Growth	-89.59 %	-74.82 %	493.71 %	30.87 %	138.7 %
Inventory Turnover Ratio (TTM)	2.12	1.91	1.83	1.17	1.69
GLS's Total Ranking	# 1239	# 1383	# 1740	# 0	# 0
Average inventory processing period	172	191	200	311	216
Seq. Inventory Growth	-4.26 %	-13.46 %	-62.71 %	-2.18 %	15.64 %
Seq. Cost of Sales Growth	-59.74 %	-91.32 %	293.89 %	-24.45 %	-2.58 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 72
Healthcare Sector	# 215
Overall Market	# 1239

Inventory Turnover Ratio Statistics
High	Average	Low
2.12	1.95	1.83
(Jun 30 2023)

GLS Company Profile >> Back to GLS Efficiency Comparisons >> Compare GLS Inventory Turnover Ratio to its Competitors

Financial Statements
Gelesis Holdings Inc 's Inventories	$ 6 Millions	Visit GLS's Balance sheet
Gelesis Holdings Inc 's Cost of Revenues TTM	$ 20 Millions	Visit GLS's Income Statement
What are GLS's Sales?		Visit GLS's Sales by Segment

Other Inventory Turnover Ratios
Gelesis Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
GLS's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for GLS's Competitors
Inventory Turnover Ratio for GLS's Suppliers
Inventory Turnover Ratio for GLS's Customers

You may also want to know
GLS's Sales Growth Rates	GLS's Pe Price to earnings ratio	GLS's Receivables Turnover Ratio	GLS's Stock Quote
GLS's Net Income Growth Rates	GLS's Ps Price to Sales ratio	GLS's Sales per Employee	GLS's Asset Turnover Ratio
GLS's Net Margin	GLS's Pb Price to Book ratio	GLS's Financial Strength Ratios	GLS's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2023	Inventories at quarter ending Jun 30 2023
Irhythm Holdings Inc	9.24	$ 139.619 Millions	$ 15 Millions
Dermtech Inc	9.13	$ 13.865 Millions	$ 2 Millions
Prophase Labs Inc	8.93	$ 37.550 Millions	$ 4 Millions
Bionexus Gene Lab Corp	8.67	$ 8.968 Millions	$ 1 Millions
Kaya Holdings Inc	8.64	$ 0.139 Millions	$ 0 Millions
Castle Biosciences Inc	8.60	$ 39.619 Millions	$ 5 Millions
Charles River Laboratories International inc	8.55	$ 2,277.407 Millions	$ 266 Millions
Camp4 Therapeutics Corporation	8.20	$ 190.689 Millions	$ 23 Millions
Cardiff Lexington Corporation	7.95	$ 4.293 Millions	$ 1 Millions
Kewaunee Scientific Corporation	7.87	$ 176.979 Millions	$ 22 Millions
National Vision Holdings Inc	7.82	$ 956.874 Millions	$ 122 Millions
Nutriband Inc	7.22	$ 1.358 Millions	$ 0 Millions
Revvity Inc	7.15	$ 3,727.599 Millions	$ 521 Millions
Star Equity Holdings Inc	6.88	$ 65.669 Millions	$ 10 Millions
Dmk Pharmaceuticals Corporation	6.76	$ 6.184 Millions	$ 1 Millions
Agape Atp Corporation	6.64	$ 0.720 Millions	$ 0 Millions
Collegium Pharmaceutical Inc	6.50	$ 276.370 Millions	$ 43 Millions
Hims and Hers Health Inc	6.49	$ 139.594 Millions	$ 22 Millions
Societal Cdmo Inc	6.35	$ 70.098 Millions	$ 11 Millions
Fonar Corporation	6.27	$ 16.183 Millions	$ 3 Millions
Opko Health Inc	6.27	$ 461.597 Millions	$ 74 Millions
Zai Lab Limited	6.22	$ 86.068 Millions	$ 14 Millions
Veracyte Inc	6.21	$ 82.191 Millions	$ 13 Millions
Inogen Inc	6.09	$ 212.231 Millions	$ 35 Millions
Alimera Sciences Inc	6.07	$ 8.584 Millions	$ 1 Millions
Prosomnus Inc	5.97	$ 5.000 Millions	$ 1 Millions
Patterson Companies Inc	5.84	$ 5,144.394 Millions	$ 881 Millions
Incyte Corporation	5.80	$ 238.895 Millions	$ 41 Millions
Cytosorbents Corporation	5.76	$ 15.524 Millions	$ 3 Millions
Carlisle Companies Incorporated	5.51	$ 4,042.000 Millions	$ 733 Millions

Date modified: 2026-09-08T15:11:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.